AzTrials
AzTrials

HealthyNCT06356181

Training Adaptations With and Without Ventilatory Training Device

A study testing Respiratory Maximus Training Device and No Respiratory Training Device in people with Healthy, run by University of South Carolina at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project aims to assess the effectiveness of using a Respiratory Muscle Training (RMT) device during high-intensity functional training (HIFT) to improve fitness and ventilatory parameters. Primary outcome measures include aerobic, anaerobic, and HIFT measures. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Respiratory Maximus Training Device and No Respiratory Training Device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
18 Mar 2024to 29 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Males and females between the ages of 18 and 35 (inclusive) who participate in at least 150 minutes per week of physical activity.
  • Have not participated in HIFT training in the last 6 months.
  • Provided written and dated informed consent to participate in the study.
  • In good health as determined by medical history and is cleared for exercise.
  • Participant will be asked about dietary supplementation use within the past 6 months.
  • If participant began taking a supplement within the past month, subject will be asked to discontinue supplement use followed by a 2-week washout prior to participation.
  • In all other cases, we will request that participant maintain supplement use.

Who cannot join

  • Any musculoskeletal injuries that would prevent exercising.
  • Any metabolic disorder including known electrolyte abnormalities, diabetes, uncontrolled thyroid disease, adrenal disease or hypogonadism.
  • Any inborn error of metabolism.
  • History of hepatorenal, musculoskeletal, autoimmune, or neurologic disease.
  • Participants with a personal history of heart disease, high blood pressure (systolic >140 mm Hg \& diastolic >90 mm Hg),
  • Participants who are pregnant, planning to become pregnant, or lactating.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of South Carolina Sport Science Lab

    Columbia, South Carolina, 29208

Other trials in United States

About this study

Official title: High-Intensity Functional Training Adaptations With and Without Maximus Ventilatory Training Device

This project aims to assess the effectiveness of using a Respiratory Muscle Training (RMT) device during high-intensity functional training (HIFT) to improve fitness and ventilatory parameters. Primary outcome measures include aerobic, anaerobic, and HIFT measures. Secondary measures include sleep, affect, and mood state questionnaires. Participants will be randomized into one of two groups: with the RMT device and without the RMT device.

Read the detailed description

This study assesses the impact of a ventilatory training device, similar to a sports mouth guard worn during exercise, on various performance outcomes. The main questions it aims to answer are:

  • Does the device improve fitness parameters: high-intensity functional training, anaerobic capacity, anaerobic peak and mean power output, maximal oxygen uptake, ventilatory threshold, and blood lactate responses to training?
  • Does the device improve spirometry measures?

Researchers will compare 6 weeks of training with the ventilatory training device to those without the training device.

Participants will:

  • Take part in a total of 8 weeks of study-related activity.
  • Complete six total one- to two-hour pre- and post-testing sessions, which include a maximal oxygen uptake test, high-intensity functional training, body composition, spirometry, anaerobic power and capacity testing.
  • Complete six weeks of 45-minute high-intensity functional training, three days per week.
Conditions
Healthy
Being tested
Respiratory Maximus Training Device, No Respiratory Training Device
Keywords
high-intensity functional training, respiratory training device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Respiratory Maximus Training DeviceDevice

    Those in the intervention group will wear the respiratory training device for 3 days per week of high-intensity functional training over 6-weeks.

  • No Respiratory Training DeviceDevice

    Those in the control group will train for 3 days per week of high-intensity functional training over 6-weeks.

Study groups in NCT06356181
Study groupRoleWhat they receive
ExperimentalExperimentalParticipants in this group will undergo 6 weeks of high-intensity functional training using the respiratory muscle training device.
Receives: Device: Respiratory Maximus Training Device
ControlActive comparatorParticipants in this group will undergo 6 weeks of high-intensity functional training without using the respiratory muscle training device.
Receives: Device: No Respiratory Training Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in spirometry

    Spirometry measures of forced vital capacity (FVC) (L), forced expiratory volume at one second (FEV1) (L), and the ratio of FEV1/FVC %

    Measured: Baseline and Week 8

  2. Changes in aerobic capacity

    Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry.

    Measured: Baseline and Week 8

  3. Changes in peak power

    Assessed via a cycle-ergometer based maximal graded exercise test

    Measured: Baseline and Week 8

  4. Changes in ventilatory threshold

    Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry.

    Measured: Baseline and Week 8

  5. Changes in countermovement jump

    Assessed via force plates

    Measured: Baseline and Week 8

  6. Changes in anaerobic capacity

    Assessed via 30-second Wingate test.

    Measured: Baseline and Week 8

  7. Changes in high-intensity functional training test

    Assessed via a high-intensity functional training circuit composed of rows, pushups, and squats

    Measured: Baseline and Week 8

  8. Changes in heart rate at ventilatory threshold

    Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry.

    Measured: Baseline and Week 8

Secondary outcomes (6)
  1. Changes in body composition

    Body fat percentage, fat-free mass, and fat mass via air-displacement plethysmography.

    Measured: Baseline and Week 8

  2. Changes in sleep quality

    Assessed by Pittsburgh Sleep Quality Index. The minimum score is 0 and the maximum score is 40. Higher scores mean a worse outcome.

    Measured: Baseline and Weeks 3, 5, and 7

  3. Changes in total mood disturbances

    Assessed by the Profile of Mood States (POMS). The total mood is calculated by adding the negative subscales (tension, depression, fatigue, confusion, and anger) and subtracting the positive subscales (vigor, esteem-related affect). Minimum score of -36 and max score of 200. Lower scores for total mood disturbance are considered better.

    Measured: Baseline and Weeks 3, 5, and 7

  4. Changes in positive mood and emotion

    Assessed by the Positive and Negative Affect Schedule. Min values of 0 and max of 50, higher scores indicate more positive moods and emotions.

    Measured: Baseline and Weeks 3, 5, and 7

  5. Change in blood lactate responses

    Biochemical responses to exercise. Blood lactate sampled pre and post exercise during the last training day of the week.

    Measured: Weeks 3, 5, and 7

  6. Changes in negative mood and emotion

    Assessed by the Positive and Negative Affect Schedule. Min values of 0 and max of 50, higher scores indicate more negative moods and emotions with lower scores indicating less negative moods and emotions.

    Measured: Baseline and Weeks 3, 5, and 7.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2024
  2. Study start18 Mar 2024
  3. Primary completion28 Oct 2024
  4. Study completion29 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06356181
Sponsor's protocol ID
Pro00135143
Status last verified
Nov 2024
First submitted
27 Mar 2024
Last updated
2 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chandler AJ, Martin-Diala C, Mastrofini GF, Stray-Gundersen S, Artsinger R, Nakagawa N, Arent SM. The Effects of High-Intensity Functional Training With a Respiratory Muscle Training Device on Performance, Mood, and Ventilatory Function. J Strength Cond Res. 2026 Oct 5. doi: 10.1519/JSC.0000000000005692. Online ahead of print. No abstract available.

    PubMed 42832180

Questions about this trial

What is this clinical trial studying?

A study testing Respiratory Maximus Training Device and No Respiratory Training Device in people with Healthy, run by University of South Carolina at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in spirometry (time frame: Baseline and Week 8). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06356181, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06356181 | AzTrials